ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions

A. Bourdin, L. Bjermer, C. Brightling et al.

Source: Guideline 2019
Number: 2019

Full text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bourdin, L. Bjermer, C. Brightling et al.. ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions. Guideline 2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Answering questions and challenges in the management of health smoking and COPD patients
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020


What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018



The critical statement of the asthma expert
Source: Annual Congress 2012 - Endo meets obstruction: the new endoscopic treatment options for obstructive lung diseases
Year: 2012


A survey of specialist opinions on biomarker use in severe asthma in Australia: scepticism but hope?
Source: ERJ Open Res, 6 (2) 00113-2020; 10.1183/23120541.00113-2020
Year: 2020



The national review of asthma deaths: what did we learn and what needs to change?
Source: Breathe 2015; 11:14-24
Year: 2015



How do the new guidelines work? Practical approach to the new guidelines for asthma diagnosis in children, discussion and Q&A
Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years
Year: 2021


What are the important questions in our approach to those with asthma?
Source:
Year: 2008

Facing the challenges of self-management in COPD: how do people adapt to the disease, its symptoms and resulting limitations?
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

Implementation of personalized treatment of asthma by improved phenotyping: Critical review of knowledge gaps and unmet research needs by the European asthma research & innovation partnership (EARIP) expert panel
Source: International Congress 2016 – Phenotyping asthma
Year: 2016


An ATS/ERS report: 100 key questions and needs in occupational asthma
Source: Eur Respir J 2006; 27: 607-614
Year: 2006



Age-related differences in perceived asthma control in childhood: guidelines and reality
Source: Eur Respir J 2002; 20: 880-889
Year: 2002



Translating research into practice: how are guidelines implemented?
Source: Eur Respir J 2003; 21: 23S-29S
Year: 2003



Challenges in COPD exacerbations and future research and unknowns
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013

Selfmanagement by eHealth in asthma and COPD patients: with or without the professional.
Source: International Congress 2017 – Primary care management of asthma and COPD
Year: 2017


Patient concerns regarding asthma, COPD and regular therapies: Results from a European survey
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010


Decision analytic models in COPD/asthma: A critical review of current evidence
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016


Action plans with brief patient education only for exacerbations in COPD: A systematic review
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


The management of work-related asthma guidelines: a broader perspective
Source: Eur Respir Rev 2012; 21: 125-139
Year: 2012



"It‘s like living with a time bomb"– European patients‘ perspective on severe asthma symptoms
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005